Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,165,500
Total 13F shares
5,996,154
Share change
+5,350,360
Total reported value
$14,097,585
Price per share
$2.35
Number of holders
14
Value change
+$12,574,926
Number of buys
8
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q1 2020

As of 31 Mar 2020, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,996,154 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, Psagot Investment House Ltd., BRIDGEWAY CAPITAL MANAGEMENT INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, JANE STREET GROUP, LLC, Measured Wealth Private Client Group, LLC, SG Americas Securities, LLC, GROUP ONE TRADING, L.P., and FEDERATED HERMES, INC.. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.